3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid

3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid Struktur
1336964-26-1
CAS-Nr.
1336964-26-1
Englisch Name:
3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid
Synonyma:
3-([1,4'-bipiperidin]-1'-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid;4-Quinolinecarboxylic acid, 3-([1,4'-bipiperidin]-1'-ylmethyl)-7-bromo-2-[3-(trifluoromethyl)phenyl]-;3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid
CBNumber:
CB59291466
Summenformel:
C28H29BrF3N3O2
Molgewicht:
576.45
MOL-Datei:
1336964-26-1.mol

3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid Eigenschaften

Siedepunkt:
632.8±55.0 °C(Predicted)
Dichte
1.434±0.06 g/cm3(Predicted)
pka
9.50±0.20(Predicted)

Sicherheit

3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Jingmo (Xiamen) Biotechnology Co., Ltd 13621943973
sales@jamxmpharmatech.com China 1105 58

  • 3-([1,4''-Bipiperidin]-1''-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid
  • 4-Quinolinecarboxylic acid, 3-([1,4'-bipiperidin]-1'-ylmethyl)-7-bromo-2-[3-(trifluoromethyl)phenyl]-
  • 3-([1,4'-bipiperidin]-1'-ylmethyl)-7-bromo-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxylic acid
  • 1336964-26-1
Copyright 2019 © ChemicalBook. All rights reserved